Joseph E. Grossman

909 total citations
30 papers, 290 citations indexed

About

Joseph E. Grossman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joseph E. Grossman has authored 30 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Joseph E. Grossman's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (9 papers) and Cancer Genomics and Diagnostics (5 papers). Joseph E. Grossman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (9 papers) and Cancer Genomics and Diagnostics (5 papers). Joseph E. Grossman collaborates with scholars based in United States, United Kingdom and Spain. Joseph E. Grossman's co-authors include Manuel Hidalgo, Bruno Bockorny, Taru Muranen, Marcin Iwanicki, Stephen Lyle, Olga Pozdnyakova, Ling Huang, M Dezfulian, Qingda Meng and Senthil K. Muthuswamy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Joseph E. Grossman

28 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph E. Grossman United States 8 193 77 62 58 49 30 290
Ahmed Raji Iraq 3 204 1.1× 132 1.7× 97 1.6× 68 1.2× 42 0.9× 8 319
Longwen Xu China 10 172 0.9× 81 1.1× 185 3.0× 61 1.1× 94 1.9× 24 361
Matthen Mathew United States 8 165 0.9× 108 1.4× 130 2.1× 58 1.0× 87 1.8× 13 321
Betül Gök Yavuz United States 6 172 0.9× 137 1.8× 120 1.9× 34 0.6× 69 1.4× 12 325
S Buchholz Germany 5 204 1.1× 88 1.1× 138 2.2× 36 0.6× 89 1.8× 11 333
Qiuyao Wu China 7 142 0.7× 82 1.1× 158 2.5× 42 0.7× 110 2.2× 10 312
Songwei Feng China 11 84 0.4× 61 0.8× 130 2.1× 75 1.3× 69 1.4× 21 266
Manuel Cabeza-Segura Spain 5 126 0.7× 103 1.3× 116 1.9× 97 1.7× 98 2.0× 9 311
Qing Jiang China 7 130 0.7× 68 0.9× 104 1.7× 71 1.2× 74 1.5× 12 292

Countries citing papers authored by Joseph E. Grossman

Since Specialization
Citations

This map shows the geographic impact of Joseph E. Grossman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph E. Grossman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph E. Grossman more than expected).

Fields of papers citing papers by Joseph E. Grossman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph E. Grossman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph E. Grossman. The network helps show where Joseph E. Grossman may publish in the future.

Co-authorship network of co-authors of Joseph E. Grossman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph E. Grossman. A scholar is included among the top collaborators of Joseph E. Grossman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph E. Grossman. Joseph E. Grossman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilky, Breelyn A., Gary K. Schwartz, Michael S. Gordon, et al.. (2025). Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas. Journal of Clinical Oncology. 43(11). 1358–1368. 9 indexed citations
2.
Garmezy, Benjamin, Joseph E. Grossman, Jennifer S. Buell, et al.. (2025). Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumor. Oncogene. 44(31). 2792–2795.
3.
4.
Bockorny, Bruno, Lakshmi Muthuswamy, Ling Huang, et al.. (2024). A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. eLife. 12. 3 indexed citations
5.
6.
Wilky, Breelyn A., Jonathan C. Trent, Apostolia M. Tsimberidou, et al.. (2024). 1726MO Updated efficacy and safety of botensilimab plus balstilimab in patients with refractory metastatic sarcoma from an expanded phase I study. Annals of Oncology. 35. S1034–S1034. 1 indexed citations
7.
Bockorny, Bruno, Lakshmi Muthuswamy, Ling Huang, et al.. (2023). A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancer. eLife. 12. 3 indexed citations
8.
Levey, Daniel L., Dhan Chand, Margaret K. Wilkens, et al.. (2023). Treatment with doxorubicin and PD-1/CTLA-4 blockade improves T cell activation and anti-tumor efficacy in MCA-205 murine fibrosarcoma. The Journal of Immunology. 210(Supplement_1). 63.18–63.18. 2 indexed citations
9.
Cutsem, E. Van, Marwan Fakih, Neil H. Segal, et al.. (2023). 116TiP Randomized, open-label, phase II study of botensilimab (BOT) alone and in combination with balstilimab (BAL) versus standard-of-care in patients with refractory metastatic colorectal cancer. Immuno-Oncology Technology. 20. 100588–100588. 1 indexed citations
10.
Faleck, David M., et al.. (2023). Accelerating the Evolution of Immune-Related Enterocolitis Management. Journal of Clinical Oncology. 41(17). 3110–3115. 4 indexed citations
11.
Hidalgo, Manuel, Rocio García‐Carbonero, Kian‐Huat Lim, et al.. (2022). A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas. Cancer Research Communications. 2(11). 1326–1333. 5 indexed citations
12.
Bockorny, Bruno, Joseph E. Grossman, & Manuel Hidalgo. (2022). Facts and Hopes in Immunotherapy of Pancreatic Cancer. Clinical Cancer Research. 28(21). 4606–4617. 49 indexed citations
13.
Grossman, Joseph E., et al.. (2022). Primary extraskeletal osteosarcoma in a bladder diverticulum. Urology Case Reports. 45. 102214–102214. 1 indexed citations
14.
Meng, Qingda, Shanshan Xie, G. Kenneth Gray, et al.. (2021). Empirical identification and validation of tumor-targeting T cell receptors from circulation using autologous pancreatic tumor organoids. Journal for ImmunoTherapy of Cancer. 9(11). e003213–e003213. 54 indexed citations
15.
El-Khoueiry, Anthony B., Andrea J. Bullock, Apostolia M. Tsimberidou, et al.. (2021). 479 AGEN1181, an Fc-enhanced anti-CTLA-4 antibody, alone and in combination with balstilimab (anti-PD-1) in patients with advanced solid tumors: Initial phase I results. SHILAP Revista de lepidopterología. A509–A509. 6 indexed citations
16.
Grossman, Joseph E., et al.. (2020). The Interplay of the Extracellular Matrix and Stromal Cells as a Drug Target in Stroma-Rich Cancers. Trends in Pharmacological Sciences. 41(3). 183–198. 55 indexed citations
17.
Grossman, Joseph E., Yubo Wu, Huihui Ye, & Rupal S. Bhatt. (2018). Case of Basal Cell Carcinoma of the Prostate Successfully Treated Before and After a BRCA2 Reversion Mutation. JCO Precision Oncology. 2(2). 1–5. 5 indexed citations
18.
Harrington, Colin J., Joseph E. Grossman, & Katherine Richman. (2013). Psychogenic Adipsia Presenting as Acute Kidney Injury: Case Report and Review of Disorders of Sodium and Water Metabolism in Psychiatric Illness. Psychosomatics. 55(3). 289–295. 2 indexed citations
19.
Pozdnyakova, Olga, et al.. (2009). The hair follicle barrier to involvement by malignant melanoma. Cancer. 115(6). 1267–1275. 20 indexed citations
20.
Tan, Yi, et al.. (1994). Fibroblast Growth Factor and Cyclic AMP (cAMP) Synergistically Activate Gene Expression at a cAMP Response Element. Molecular and Cellular Biology. 14(11). 7546–7556. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Raji Breakdown of academic impact, for papers by Longwen Xu Breakdown of academic impact, for papers by Matthen Mathew Breakdown of academic impact, for papers by Betül Gök Yavuz Breakdown of academic impact, for papers by S Buchholz Breakdown of academic impact, for papers by Qiuyao Wu Breakdown of academic impact, for papers by Songwei Feng Breakdown of academic impact, for papers by Manuel Cabeza-Segura Breakdown of academic impact, for papers by Qing Jiang
Rankless by CCL
2026